Mike has been Chief Security Officer at Takeda since August 2018, where he partners with business leadership to prioritize the protection of critical information assets, by implementing and monitoring the controls necessary to mitigate security risks and assure the confidentiality, availability and integrity of Takeda’s data. Mike and his team design and execute measures to identify and protect the information and data supporting Takeda’s patients, people, biopharmaceutical research, development, global supply chain and commercial businesses across 110 countries, and ensure IT systems are managed in accordance with compliance, quality, legal and regulatory requirements.
Prior to joining Takeda, Mike has led due diligence and integration efforts for more than 50 acquisition and divesture transactions throughout his career at Intel Corp, SmithKline Beecham, GlaxoSmithKline, Actavis and Allergan. These efforts included four major acquisitions and one significant divestiture each valued at more than $40 billion.
Mike has received two Information Security Executive of the Year awards within the Healthcare industry and is a regular speaker and expert panelist on information protection and cybersecurity. Mike passionately advocates cross-industry sharing and collaboration, and serves on the Board of Directors for the Health Information Security & Analysis Center (H-ISAC), where he also chairs the Products & Services Committee. Mike is a venture capital Board Advisor for Cyberstarts, and sits on the executive advisory boards for Okta and Armis.
Mike holds an MBA from St. Joseph’s University and a Bachelor of Science in Computer Engineering from the University of Notre Dame. Mike splits his time between his home office in Cambridge, MA USA, as well as offices in Zurich and Tokyo.